Biotech entity
clinical-trial is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Coronary Artery Disease, the most common co-covered peer. Breast Arterial Calcification appears in 1 tracked Biotech story from February 25, 2026.
Last mentioned: Feb 25, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
clinical-trial is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention Coronary Artery Disease, the most common co-covered peer. Breast Arterial Calcification appears in 1 tracked Biotech story from February 25, 2026. The tracked stories average 2 original sources each.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 16 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Breast Arterial Calcification. Shared-story counts are live from our verified record — not editorial picks.
Clinical research reveals that routine mammograms can detect Breast Arterial Calcification, a potent early indicator of heart disease in women. This discovery could transform standard breast cancer screenings into a dual-purpose diagnostic tool for the leading cause of female mortality.
Breast Arterial Calcification is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
